IO Biotech, Inc.IOBTNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P5
Near historical low
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -14.34% |
| Q2 2025 | 5.05% |
| Q1 2025 | 7.26% |
| Q4 2024 | -8.89% |
| Q3 2024 | 11.88% |
| Q2 2024 | -3.59% |
| Q1 2024 | -8.64% |
| Q4 2023 | 10.24% |
| Q3 2023 | 9.18% |
| Q2 2023 | -11.78% |
| Q1 2023 | 1.46% |
| Q4 2022 | -1.32% |
| Q3 2022 | -1.55% |
| Q2 2022 | -11.47% |
| Q1 2022 | 35.30% |
| Q4 2021 | 70.04% |
| Q3 2021 | 29.63% |
| Q2 2021 | 132.95% |
| Q1 2021 | 193.31% |
| Q4 2020 | -49.69% |
| Q3 2020 | 87.12% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |